IPIC2015 was a great success with 700 participants from over 70 countries in attendance! The second International Primary Immunodeficiencies Congress was held on the 5-6  November 2015 in the beautiful city of Budapest, Hungary.

Building on the outcomes of IPIC2013 held in Estoril, Portugal, the 2015 edition further explored key clinical management developments in the field of PIDs, putting the patient’s interest at the centre of all discussions. The uniqueness of IPIC comes from the fact that the programme is clinically orientated and prepared with the input from the key PID stakeholders: doctors, patients and nurses.

The congress programme featured an array of world renowned experts such as Prof Alain Fischer, Prof Amos Etzioni, Prof Bobby Gaspar and other leading stakeholders from the PID community who shared their experience and provided invaluable perspectives on major clinical considerations. The various sessions and symposia covered a broad range of issues such as the management of gastro-intestinal complications, severe combined immunodeficiencies (SCID), the promises and pitfalls of new genetics, the importance of patient registries treatment options among others.

IPIC2015 was very well attended by physicians and nurses but IPOPI’s national member organisations were also very well represented.

IPOPI is thankful to the IPIC2015 sponsors who held made the congress a reality:
Platinum Baxalta Octapharma
Gold Grifols Kedrion
Silver CSL Behring Sigma Tau

Please visit www.ipic2015.com for more details.